N@N

CRME, KOPN, IPAR, NRP, ALNY, WTI Are Seasonally Ripe To Go Down In the Next Five Weeks

July 30, 2012 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of CARDIOME PHARMA CORP (NASDAQ:CRME), Kopin Corp (NASDAQ:KOPN), Inter Parfums Inc (NASDAQ:IPAR), Natural Resource Partners LP (NYSE:NRP), Alnylam Pharmaceuticals Inc (NASDAQ:ALNY), W&T Offshore Inc (NYSE:WTI) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at: http://www.squeezetrigger.com/services/strat/mh.php

The following stocks are expected to go Down:

  Symbol  Company                          Expected Return  Odds                 By The Following Date
  CRME    CARDIOME PHARMA CORP             -13.42%          87.50% (7 of 8)      Wednesday, August 15th 2012
  KOPN    Kopin Corp                       -5.51%           91.67% (11 of 12)    Wednesday, August 1st 2012
  IPAR    Inter Parfums Inc                -10.31%          91.67% (11 of 12)    Thursday, August 30th 2012
  NRP     Natural Resource Partners LP     -7.86%           88.89% (8 of 9)      Monday, August 13th 2012
  ALNY    Alnylam Pharmaceuticals Inc      -10.86%          87.50% (7 of 8)      Wednesday, August 15th 2012
  WTI     W&T Offshore Inc                 -10.65%          100.00% (7 of 7)     Friday, August 17th 2012

CARDIOME PHARMA CORP (NASDAQ:CRME) - Cardiome Pharma Corp., a life sciences company, engages in developing proprietary drugs to treat or prevent cardiovascular and other diseases. The company offers BRINAVESS, a product approved for marketing in the European Union, Iceland, and Norway for the conversion of recent onset atrial fibrillation to sinus rhythm in adults. It also has clinical programs, which focuses on the treatment of atrial fibrillation, an arrhythmia (or abnormal rhythm) of the upper chambers of the heart. The company has a phase 1 program for GED-aPC, an engineered analog of recombinant human activated Protein C that completed phase I clinical trials for the treatment of infectious disease. In addition, Cardiome Pharma Corp. has pre-clinical projects that focus on cardiac diseases, ion channel conditions, and other indications. It also has a collaboration and license agreement with Merck & Co., Inc. (Merck), for the development and commercialization of vernakalant; and Astellas Pharma US, Inc. to develop, make, and sell intravenous or injectable formulations of vernakalant in North America. The company was formerly known as Nortran Pharmaceuticals Inc. and changed its name to Cardiome Pharma Corp. in June 2001. Cardiome Pharma Corp. was founded in 1986 and is headquartered in Vancouver, Canada.

Kopin Corp (NASDAQ:KOPN) - Kopin Corporation designs, manufactures, and markets III-V products and miniature flat panel displays. The company offers gallium arsenide-based heterojunction bipolar transistor (HBT) wafers, and other commercial semiconductor products that use gallium nitride and gallium arsenide-based substrates. Its HBT wafers help in developing gallium arsenide power amplifiers for wireless handsets. These wafers are also used in code division multiple access, global system mobile and time division multiple access power amplifiers, and third generation wireless handset standards, as well as in high-speed fiber optic switching; and the fabrication of power amplifiers for devices that communicate using wireless fidelity or WiFi integrated circuits. The company also offers CyberDisplay products, which are used in military devices, such as thermal weapon sights and consumer devices, including camcorders, digital cameras, and devices that are capable of browsing the Internet using digital wireless devices and viewing video from other consumer electronics devices. Kopin Corporation sells its III-V products directly to integrated circuit manufacturers in the United States and Asia. The company sells its products directly, as well as through distributors to original equipment manufacturers, and prime contractors of the U.S. government or foreign governments. Kopin Corporation was founded in 1984 and is headquartered Taunton, Massachusetts.

Inter Parfums Inc (NASDAQ:IPAR) - Inter Parfums, Inc., together with its subsidiaries, engages in the manufacture, marketing, and distribution of various fragrances and fragrance related products primarily in the United States and Europe. The company produces and distributes its prestige fragrance products under license agreements with brand owners. Its brand portfolio includes Burberry, Lanvin, Van Cleef & Arpels, Paul Smith, Jimmy Choo, Montblanc, S.T. Dupont, and Nickel brands. The company also involves in designing, marketing, and distributing mass market products, such as alternative designer fragrances; personal care products; and Aziza line of eye shadow kits, mascara, and pencils, as well as health and beauty aids comprising shampoo, conditioner, hand lotion, and baby oil under its Intimate and Johnson Parker brands. Inter Parfums offers its specialty retail, and mass-market fragrance and fragrance related products under trademarks owned by the company or pursuant to license or other agreements with the owners of the Gap, Banana Republic, New York & Company, Brooks Brothers, bebe, and Jordache trademarks. The company distributes its products through independent distribution companies, as well as through various duty-free operators consisting of airports and airlines, and select vacation destinations. It sells its products to specialty and department stores, perfumeries, specialty retailers, mass-market retailers, supermarkets, and wholesalers and distributors. The company was formerly known as Jean Philippe Fragrances, Inc. and changed its name to Inter Parfums, Inc. in July 1999. Inter Parfums, Inc. was founded in 1985 and is headquartered in New York, New York.

Natural Resource Partners LP (NYSE:NRP) - Natural Resource Partners L.P., through its subsidiaries, engages in the ownership and management of coal properties in Appalachia, the Illinois Basin, and the Northern Powder River Basin regions of the United States. The company leases its properties to coal mine operators in exchange for royalty payments. It also owns preparation plants, coal handling facilities, and transportation infrastructure, as well as owns and manages aggregate reserves in Washington, Texas, Arizona, and West Virginia. As of December 31, 2009, the company owned or controlled approximately 2.1 billion tons of proven and probable coal reserves. Its coal and aggregate reserves were subject to 214 leases with 76 lessees. NRP (GP) LP operates as the general partner of Natural Resource Partners L.P. The company was founded in 2002 and is based in Houston, Texas.

Alnylam Pharmaceuticals Inc (NASDAQ:ALNY) - Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics based on RNA interference (RNAi). Its lead RNAi therapeutic program includes ALN-RSV01, which is in Phase II clinical trial for the treatment of human respiratory syncytial virus (RSV) infection. The companys product pipeline also comprises ALN-VSP, a Phase I clinical trial product to treat liver cancers. Its products under development stage include ALN-RSV02 for the treatment of RSV infection; ALN TTR01 and ALN TTR02 to treat TTR-Mediated Amyloidosis; ALN-PCS for the treatment of PCSK9/Hypercholesterolemia; and ALN-HTT to treat Huntingtons disease. It has license and collaboration agreements with Roche to develop and commercialize therapeutic products that function through RNAi; Takeda for the development and commercialization of RNAi therapeutics; and with Medtronic Inc. and CHDI Foundation, Inc. to advance ALN-HTT, a novel drug-device combination for the treatment of Huntington's disease. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.

W&T Offshore Inc (NYSE:WTI) - W&T Offshore, Inc. engages in the acquisition, exploitation, exploration, and development of oil and natural gas properties primarily in the Gulf of Mexico. As of April 26, 2011, it had working interests in approximately 68 fields in federal waters, state waters, and onshore. The company was founded in 1983 and is based in Houston, Texas.

SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com

www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.

INVESTMENTS & TRADING

SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

About SQUEEZETRIGGER.COM

WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.

SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.

Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.

Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641